IRF1 and Alzheimer disease: By recording swimming speed and the number of crossing times within 1 min after the platform was removed on day 7, we found that the 3xTg-AD mice injected with AAV-IRF-1 significantly exhibited more crossing times in the target quadrant compared to control group (Fig. 6C-D), maintaining the same swimming speed (Fig. 6B).